Delivra Health Issues News Release Amendment Regarding Proposed Shares for Debt Transaction

Rhea-AI Summary

Delivra Health Brands (OTCQB: DHBUF) corrected the proposed share issuance for a settlement of approximately $90,000 in outstanding service-related payables. The transaction would issue 999,999 common shares at a deemed price of $0.09 per share, rather than the 9,999,999 shares reported on November 11, 2026, which was a typographical error.

The settlement remains subject to TSX Venture Exchange approval. Immediately afterward, the company would have 32,261,780 shares issued and outstanding on a non-diluted basis. All other aspects of the earlier announcement remain effective.

1 point · 0 major

MixediHow this balance works

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

How the balance worksHow Sentiment works

0 major · 2 points

Hollow bars mark forward-looking points. How the balance works

Positive

• Moderate point. Forward-looking: it has not happened yet and may not happen.Proposed share settlement would satisfy approximately $90,000 in outstanding service-related payables. 4.8% of market cap

Negative

• Moderate point. Forward-looking: it has not happened yet and may not happen.Proposed issuance of 999,999 common shares at $0.09 per share would dilute existing holders.
• Minor pointDebt settlement remains subject to TSX Venture Exchange approval.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Vancouver, British Columbia--(Newsfile Corp. - November 13, 2026) - Delivra Health Brands Inc. (TSXV: DHB) (OTCQB: DHBUF) ("Delivra Health" or the "Company"), hereby issues a correction to its news release dated November 11, 2026 (the "Prior Release") regarding a shares for payables settlement agreement to satisfy an aggregate of approximately $90,000 of the Company's outstanding payables related to services provided to the Company (the "Debt Settlement Transaction"). Subject to TSX Venture Exchange ("TSX-V") approval, the number of common shares of the Company (the "Shares") to be issued under the Debt Settlement Transaction will be 999,999 Shares at a deemed price of $0.09 per Share, rather than the 9,999,999 Shares previously reported in the Prior Release, which was a typographical error. Immediately following the Debt Settlement Transaction, the Company will have 32,261,780 Shares issued and outstanding on a non-diluted basis. All other aspects of the Prior Release are effective.

About Delivra Health Brands Inc.

Helping people take control of their health with alternative wellness solutions is what energizes the Delivra Health team! The Delivra Health portfolio features innovative brands like Dream Water™ and LivRelief™, which deliver relief from common everyday issues like chronic pain, anxiety, and sleeplessness. Delivra Health products have allowed millions of customers to reclaim their mobility, energy, and in turn, quality of life. The websites of the Company's two subsidiaries are  Dream Water™ and  LivRelief^TM. For more information, please visit  www.delivrahealthbrands.com.

Neither TSX-V nor its Regulation Services Provider (as that term is defined in the policies of the TSX-V) accept responsibility for the adequacy or accuracy of this release.

Investor Relations:
Jack Tasse
Chief Financial Officer
IR@delivrahealth.com
1-877-915-7934

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/323973

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What share count did Delivra Health correct for its proposed debt settlement?

The proposed settlement would issue 999,999 common shares, not the 9,999,999 shares previously reported. The deemed price remains $0.09 per share, and the settlement would satisfy approximately $90,000 in outstanding service-related payables, subject to TSX Venture Exchange approval.

How many shares would Delivra Health have after the debt settlement?

Immediately following the proposed debt settlement, Delivra Health would have 32,261,780 shares issued and outstanding on a non-diluted basis.